Cinryze C1-Drug Insights,2014
Phone:
+44 20 8123 2220
Fax:
+44 207 900 3970
office@marketpublishers.com
http://marketpublishers.com
Phone: +44 20 8123 2220
http://marketpublishers.com
Cinryze C1-Drug Insights,2014
Date:
Pages:
Price:
ID:
July 30, 2014
N/A
US$ 1,000.00
CF2422B1C94EN
SUMMARY
DelveInsight’s pharmaceuticals report, “Cinryze C1 - Drug Insights, 2014” provides Cinryze C1 marketed
details and API Manufacturers details across the globe along with the location. In addition, it covers sales
estimates for the US, detailed clinical assessment of the drug, patent details, route of synthesis,
competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The
report also includes SWOT analysis for the drug. This report is built using data and information sourced
from DelveInsight proprietary databases, primary and secondary research using Company’s corporate
website, SEC filings, investor presentations and featured press releases, both from company and
industry-specific third party sources, put together with in-house analysis, by DelveInsight team of industry
experts.
Data Sources
The report is built using data and information sourced from proprietary databases, primary and secondary
research and in-house analysis by DelveInsight team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable
sources like search engines, News websites, Government Websites, Trade Journals, White papers,
Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available
databases.
Please note: this report requires certain updates. We have all the information available but require 3
business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the
report may be removed or altered based on the availability and relevance of data for the indicated drug.
Scope
A review of the Cinryze C1 based on information derived from company and industry-specific
sources
Coverage of the Marketed data of the Cinryze C1 on the basis of MOA, target, dosage, route of
administration, molecule type, strength, Chemical type and ATC Classification
Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF
and API Manufactures in China & India for Schizophrenia drugs with location details
Patent Expiry Timeline and Exclusivity Details
Route of Synthesis of the API
Global Forecasted Sales Figure from 2011-2015
Qualitative and quantitative assessment of market space
SWOT Analysis
Reasons to buy
Evaluate the marketing status and exclusivity details of Cinryze C1 to exploit opportunities for
generic drug development opportunities.
Cinryze C1-Drug Insights,2014
2
Phone: +44 20 8123 2220
http://marketpublishers.com
Design effective counter-strategies to gain competitive advantage by identifying the key patent
expiry details and exclusivity with respect to Cinryze C1.
API intelligence over Cinryze C1 and gaining primary intelligence over Active Ingredients
manufacturers across the globe.
Understanding the chemical route of synthesis of Cinryze C1.
Uncovering opportunities in the rapidly growing the US market
Stay ahead of competition by understanding the changing competitive landscape
Effectively plan your M&A and partnership strategies by identifying drugs with the most promising
sales potential
Make more informed business decisions from insightful and in-depth analysis of the drug’s
performance
Obtain sales forecast for currently marketed drug for 2011-2015
Table of Content
Drug Overview
Global Sales Assessment
Product Description
Mechanism of Action
Pharmacodynamic Properties
Pharmacokinetic Properties
Marketed Details for the United States
Marketed Details for the Europe
Patent Information
Patent and Exclusivity Expiry Assessment United States (US)
Patent Numbers and Expiry Details
Patent Details
Route of Synthesis
Global API Manufacturers Assessment
The United States Drug Master File (US DMF)
The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
The Active Pharmaceutical Ingredient (API) Manufacturers in the ASIA Region
The Active Pharmaceutical Ingredient (API) Manufacturers by the United States Drug Master (DMF) File
Status
The Active Pharmaceutical Ingredient (API) Manufacturers by Region
The Active Pharmaceutical Ingredient (API) Manufacturers by Location/Countries
Generic Players
The Pipeline Coverage
Clinical Trials Information
Clinical Trials by Zone
Company Profile
Summary
Company Financials
SWOT Analysis
References
Appendix
Methodology
About DelveInsight
Contact Us
Disclaimer
LIST OF TABLES
Cinryze C1, Market, Global Sales (in USD), 2014
Cinryze C1-Drug Insights,2014
3
Phone: +44 20 8123 2220
http://marketpublishers.com
Cinryze C1, Description
Cinryze C1, Marketed Details the United States (US)
Cinryze C1, Marketed Details the Europe (EU)
Cinryze C1, Patent/Exclusivity Expiry (Year), 2014
Cinryze C1, Patent Number Specific Patent Expiry (Year), 2014
Cinryze C1, Patent Details
Cinryze C1, Route of Synthesis
Cinryze C1, the United States Drug Master File (US DMF), 2014
Cinryze C1, the Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF), 2014
Cinryze C1, the API Manufacturers, China, 2014
Cinryze C1, the API Manufacturers, India, 2014
Cinryze C1, the API Manufacturers by the US DMF Status, 2014
Cinryze C1, the API Manufacturers by Region, 2014
Cinryze C1, the API Manufacturers by Location/Countries, 2014
Cinryze C1, Generic Players, 2014
Cinryze C1, Pipeline Drug Details, 2014
Cinryze C1, Clinical Trials, 2014
Cinryze C1, Clinical Trials by Zone, 2014
Company Overview, 2014
Cinryze C1, SWOT Analysis, 2014
Phase III Pipeline Therapeutics, 2014
LIST OF FIGURES
Cinryze C1, Market, Global Sales (in million USD), 2014
Cinryze C1, Global Sales % Change, 2014
Cinryze C1, Patent/Exclusivity Expiry (Year), 2014
Cinryze C1, Patent Number Specific Patent Expiry (Year), 2014
Cinryze C1, Route of synthesis
Cinryze C1, the API Manufacturers by the US DMF Status (%), 2014
Cinryze C1, the API Manufacturers by Region, 2014
Cinryze C1, the API Manufacturers by Location/Countries, 2014
Cinryze C1, Generic Players, 2014
Cinryze C1, Clinical Trials by Zone (%), 2014
Cinryze C1-Drug Insights,2014
4
Powered by TCPDF (www.tcpdf.org)
Phone: +44 20 8123 2220
http://marketpublishers.com
I would like to order:
Product name:
Product link:
Product ID:
Price:
Cinryze C1-Drug Insights,2014
http://marketpublishers.com/r/CF2422B1C94EN.html
CF2422B1C94EN
US$ 1,000.00 (Single User License / Electronic Delivery)
If you want to order Corporate License or Hard Copy, please, contact our Customer Service: office@marketpublishers.com
Payment
To pay by Credit Card (Visa, MasterCard, American Express, PayPal), please, click 'BUY NOW' button
on product page http://marketpublishers.com/r/CF2422B1C94EN.html
To pay by Wire Transfer, please, fill in your contact details in the form below:
First name:
Last name:
E-mail:
Company:
Address:
City:
Zip/Post Code:
Country:
Tel:
Fax:
Your message:
* All fields are required
Customer Signature _______________________________________
Please, note that by ordering from MarketPublisher.com you are agreeing to our Terms & Conditions at
http://marketpublishers.com/docs/terms_conditions.html
To place an order via fax simply print this form, fill in the information below
and fax the completed form to +44 20 7900 3970